Kymera Therapeutics (KYMR) Operating Income Growth (3y) (2022 - 2026)
Kymera Therapeutics (KYMR) Operating Income Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,019.86 Bn | 66,019.58 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 468.20 Bn | 463.41 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 122.50 Bn | 115.26 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 70.15 Bn | 61.39 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 55.58 Bn | 50.39 Bn | 1.41 Bn | 69.02% |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.43 Bn | 959.66 Mn | 55.96% |
| 10 | Kymera Therapeutics | 10.74 Bn | 10.09 Bn | - | -22.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.91% |
| Dec 31, 2025 | -36.34% |
| Sep 30, 2025 | -27.27% |
| Jun 30, 2025 | -27.49% |
| Mar 31, 2025 | -26.31% |
| Dec 31, 2024 | -33.43% |
| Sep 30, 2024 | -36.06% |
| Jun 30, 2024 | -27.22% |
| Mar 31, 2024 | -63.76% |
| Dec 31, 2023 | -14.75% |
| Sep 30, 2023 | -92.33% |
| Jun 30, 2023 | -45.13% |
| Mar 31, 2023 | -59.14% |
| Dec 31, 2022 | -48.56% |
| Sep 30, 2022 | -55.83% |